BY ALBERT RONNING-ANDERSSON
-
Eli Lilly pressuring Novo Nordisk in global weight-loss market
Novo Nordisk’s United States rival is tipping up the speed in greater than 55 nations, taxing the Danish pharmaceutical titan.
-
US biotech IPOs forecast for 2026 uptick after low point
Less brand-new firms on the stock market, however greater share costs and elder tasks are creating capitalists to take an extra favorable sight of biotech.
-
Genmab CEO on major Merus acquisition: More adjustments on the horizon
Genmab continues to adapt its strategy following the acquisition of Merus, with focus on prioritizing and streamlining development programs.
-
Boston Scientific gains access to FDA-approved product through US acquisition
With Valencia Technologies’ Ecoin system, Boston Scientific is targeting a brand-new dental implant market.
-
GN opens new HQ in the US: Creating space for new hires
GN, Demant, and WSA all emphasize the importance of a strong physical presence in the US, which is the largest and most important market for all of them.
-
Lift Biosciences appoints new CEO: Will open “a new front” against immunotherapy
The British biotech business is presently preparing a Stage 1 test, which will certainly start in very early 2027 to evaluate the lead prospect as a therapy for cervical cancer cel…
-
Pharmacosmos establishes Canadian office – will collaborate on sales with Pfizer
Pharmacosmos will certainly currently take care of sales of the iron shortage therapy Monofer in the healthcare facility section, which produces yearly sales of USD 72m in Canada.
-
Danish-US obesity company goes public with USD 160m in backing
The business has r & d tasks in Copenhagen and the previous Novo Nordisk head of diabetes mellitus as its clinical supervisor leading R&D.
-
“Europe could learn from the US” Bavarian CEO calls for central funding for EU bio-preparedness
DI and CBB stress the demand for raised biopreparedness due to crossbreed war. Central financing can reinforce the EU’s biopreparedness, according to chief executive officer.
-
Venture funds use “war coffers” for legal disputes in life science deals
Complicated life scientific research agreements can develop problems, which is why Sunstone and Eir Ventures alloted funds for lawful help. Sector-specific proficiency is required,…
